Font Size: a A A
Keyword [Thrombopoietin]
Result: 41 - 60 | Page: 3 of 7
41. Abnormal Platelet Kinetics In Patients With Chronic HBV Infection And The Immune Mechanism For The Associated Thrombocytopenia
42. The Possibility Of Serum TPO Level Serving As A Diagnostic Indicator Of ITP In Pregnancy
43. Alteration And Significance Of Serum TPO, IL-11and TNF-αof ITP Patients
44. Study On Neuroprotective Effect Of TPO And G-CSF In Neonatal Rats With Hypoxic-Ischemic Brain Damage
45. The Function Of TPO/c-MPL Signaling Pathway In Acute Myeloid Leukemia Bone Marrow Microenvironment
46. Recombinant Human Thrombopoietin (RhTPO)Combinating Rituximab Therapy For Immune Thrombocytopenia (ITP)
47. The Effects Of Thrombopoietin And Tansforming Growth Factor β1on The Proliferation And Differentiation Of Megakaryocyte
48. Research On Changes Of Serum TPO And TSP-1in Children With Kawasaki Disease And Its Significance
49. The Effect Of Thrombopoietin In Acute Liver Failure Model Induced By D-galactosamine
50. The Permeability Of The BBB And The Expression Of MMP-9and NF-κb After Cerebral IR And The Effects Of TPO In Rats
51. An Optimum Proposal Of High-dose Dexamethasone As An Initial Therapy In Immune Primary Thrombocytopenia And Exploring Of Double Targets Concerted Intervention
52. Comparison Of The Effect Of Astragalus Polysaccharide And Thrombopoietin On In-vivo And In-vitro Hematopoiesis
53. Clinical Study Of Recombinant Human Thrombopoietin In Management Of Primary Immune Thrombocytopenia In Pregnancy
54. Pathogenesis And Treatment Progress Of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
55. The Analysis Of Clinical Effect Of Dexamethasone Combined With RhTPO In The Treatment Of ITP
56. A Systematic Review Of Recombinant Human Thrombopoietin For The Treatment Of Immune Thrombocytopenia
57. Efficacies Of Dexamethasone In Combination With Recombinant Human Thrombopoietin And Cyclosporine A In The Treatment Of Primary Immune Thrombocytopenia
58. The Efficacy And Safety Study Of RhTPO For ITP With Different Dosing Frequency
59. The Role Of TPO Mediated Abnormal BM Niche In The Stemness Maintenance Of Leukemia Cells
60. Research On Treatment Of TPO Receptor Agonists In Primary Immune Thrombocytopenia
  <<First  <Prev  Next>  Last>>  Jump to